Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $479.24M.
ENTERPRISE VALUE (EV)
$479.24M
Puma Biotechnology, Inc.
Market Cap
$486.35M
Enterprise Value (EV)
$479.24M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | $486.35M | $479.24M |
| Evolus, Inc. (EOLS)vs › | $490.41M | $610.05M |
| Oculis Holding AG (OCS)vs › | $494.48M | $497.61M |
| Arvinas, Inc. (ARVN)vs › | $478.01M | $391.91M |
| Cerus Corporation (CERS)vs › | $475.60M | $534.42M |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.03M | $255.14M |
| Kamada Ltd. (KMDA)vs › | $470.79M | $453.11M |
| Contineum Therapeutics, Inc. (CTNM)vs › | $469.68M | $461.55M |
| Sight Sciences, Inc. (SGHT)vs › | $468.47M | $430.69M |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.10M | $540.83M |
Market Cap
$486.35M
Total Debt
$22.52M
Cash
$29.64M
Enterprise Value
$479.24M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
